TABLE 6.
Adverse events for patients randomized to Tac and CyA-ME
| Adverse event | Tac (n = 40), n (%) | CyA-ME (n = 74), n (%) |
|---|---|---|
| Tremors | 10 (12.7) | 13 (16.9) |
| Convulsions | 6 (7.6) | 6 (7.8) |
| Hypertrichosis | 8 (10.1) | 27 (35.0) |
| Gum hyperplasia | 6 (7.8) | 20 (30.0) |
| Bone disease | 8 (10.1) | 8 (10.4) |
| Diabetes | 1 (1.3) | 0 (0.0) |
| HOCM | 1 (1.3) | 0 (0.0) |
CyA-ME, cyclosporine A microemulsion; HOCM, hypertrophic cardiomyopathy; Tac, tacrolimus.